Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - European Society for Medical Oncology (ESMO)

Hairy cell leukaemia accounts for 2% of adult leukaemia, and occurs more often in men than in women. The new ESMO Clinical Practice Guidelines provide up-to-date information on the management of hairy cell leukaemia, including recommendations for diagnosis and staging, as well as detailed treatment sections referring to the latest studies and reviews.


Read full Guideline